Size: 5mg
Contents: Adipotide (5mg)
Form: Lyophilized powder
Purity: >99%
Out of stock
Adipotide 5mg is a high-purity, research-grade chimeric peptidomimetic engineered for advanced studies targeting adipose tissue vasculature. Designed exclusively for in-vitro and preclinical research, this compound is widely utilized to investigate mechanisms of adipose tissue vascularization, pro-apoptotic signaling, and metabolic pathway interactions in controlled laboratory environments.
Supplied as a lyophilized powder, Adipotide 5mg provides researchers with a precise and reliable tool for studying targeted cellular apoptosis within fat tissue blood vessels, offering a unique approach to metabolic and vascular biology research.
Adipotide stands apart due to its targeted mechanism of action—binding to specific receptors expressed on adipose endothelial cells. This selective targeting allows researchers to explore how vascular networks support fat tissue and how disrupting these pathways influences metabolic processes.
Its well-characterized structure and reproducible activity make it an essential compound for laboratories focused on obesity biology, vascular signaling, and tissue-specific apoptosis research.
Adipotide 5mg is widely recognized in scientific research for its ability to selectively target blood vessels supplying white adipose tissue. By interacting with receptors such as ANXA2 and prohibitin, it enables detailed investigation into endothelial cell function and apoptosis within fat depots.
Researchers in metabolic disease, vascular biology, and obesity-related studies rely on Adipotide for its specificity and ability to model targeted vascular disruption in adipose tissue. Its unique profile allows for deeper insights into the relationship between vasculature and fat metabolism.
Peptide Type: Chimeric peptidomimetic
Compound: Adipotide
Target Receptors: ANXA2 and prohibitin (adipose endothelial cells)
Primary Function: Adipose vasculature targeting and apoptosis research
Adipotide 5mg functions by binding to receptors expressed on the surface of adipose tissue endothelial cells, particularly ANXA2 and prohibitin. Upon binding, it initiates intracellular signaling pathways that promote apoptosis in the vascular cells supplying fat tissue.
This targeted vascular disruption reduces the support network for adipose cells, making it a powerful research tool for studying the role of blood supply in fat tissue maintenance and metabolic regulation.
Its mechanism allows researchers to investigate how selective apoptosis within adipose vasculature impacts broader metabolic and physiological processes.
Adipotide 5mg is widely utilized in laboratory studies focused on:
Its specialized mechanism makes it an essential compound for advanced metabolic and vascular research programs.
In controlled research environments, Adipotide has demonstrated strong activity in selectively inducing apoptosis within adipose-associated vasculature. Studies highlight its role as a valuable probe for understanding how blood vessel networks influence fat tissue survival and metabolic dynamics.
Ongoing research continues to explore its applications in vascular-targeted therapies, metabolic pathway modulation, and tissue-specific signaling, positioning Adipotide as a unique and powerful tool in next-generation metabolic and vascular research.
Product Name: Adipotide
Quantity: 5mg per vial
Form: Lyophilized powder
Purity: ≥99%
Store Adipotide 5mg in a cool, dry place away from direct light. Refrigeration is recommended to maintain stability, especially after reconstitution in research settings.
Adipotide 5mg is intended strictly for research and laboratory use only.
It is not approved for human consumption, veterinary use, or therapeutic applications.
All handling must be performed by qualified professionals in compliance with applicable laws and regulations.
